Graypoint LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
2,839
-75
| -3% | -$33.4K | 0.07% | 182 |
|
|
2025
Q1 | $1.41M | Buy |
2,914
+12
| +0.4% | +$5.82K | 0.09% | 155 |
|
|
2024
Q4 | $1.17M | Sell |
2,902
-104
| -3% | -$41.9K | 0.07% | 177 |
|
|
2024
Q3 | $1.4M | Buy |
3,006
+101
| +3% | +$47K | 0.09% | 153 |
|
|
2024
Q2 | $1.36M | Buy |
2,905
+578
| +25% | +$271K | 0.09% | 146 |
|
|
2024
Q1 | $973K | Buy |
2,327
+88
| +4% | +$36.8K | 0.07% | 178 |
|
|
2023
Q4 | $911K | Buy |
2,239
+189
| +9% | +$76.9K | 0.07% | 178 |
|
|
2023
Q3 | $713K | Buy |
2,050
+339
| +20% | +$118K | 0.07% | 189 |
|
|
2023
Q2 | $602K | Buy |
1,711
+579
| +51% | +$204K | 0.06% | 189 |
|
|
2023
Q1 | $357K | Buy |
1,132
+312
| +38% | +$98.3K | 0.04% | 257 |
|
|
2022
Q4 | $237K | Buy |
820
+18
| +2% | +$5.2K | 0.03% | 302 |
|
|
2022
Q3 | $232K | Buy |
+802
| New | +$232K | 0.03% | 294 |
|